Soy consumption alters endogenous estrogen metabolism in postmenopausal women

Cancer Epidemiology Biomarkers and Prevention

Volumn 9, Issue 8, 2000, Pages 781-786

  Xu, X ^a   Duncan, A M ^a   Wangen, K E ^a   Kurzer, M S ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

16ALPHA HYDROXYESTRONE; 4 HYDROXYESTRADIOL; ESTROGEN; ISOFLAVONE; PHYTOESTROGEN;

ADULT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER PREVENTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET SUPPLEMENTATION; ESTROGEN METABOLISM; FEMALE; GENOTOXICITY; HUMAN; HUMAN EXPERIMENT; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SOYBEAN;

ANALYSIS OF VARIANCE; ANTICARCINOGENIC AGENTS; BREAST NEOPLASMS; CROSS-OVER STUDIES; ESTROGENS; ESTROGENS, NON-STEROIDAL; FEMALE; HUMANS; ISOFLAVONES; LEAST-SQUARES ANALYSIS; MIDDLE AGED; PHYTOESTROGENS; PLANT PREPARATIONS; POSTMENOPAUSE; SOYBEAN PROTEINS;

EID: 0033847348     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Estrogen metabolites as bioreactive modulators of tumor initiators and promoters
2. Molecular mechanisms of estrogen carcinogenesis
3. Molecular origin of cancer: Catechol estrogen-3,4-quinones as endogenous tumor initiators
4. Induction by estrogen metabolite 16α-hydroxyestrone of genotoxic damage and aberrant proliferation in mouse mammary epithelial cells
5. Biological properties of 16α-hydroxyestrone: Implications in estrogen physiology and pathophysiology
6. Covalent binding of the endogenous estrogen 16α-hydroxyestrone to estradiol receptor in human breast cancer cells: Characterization and intranuclear localization
7. 16α-Hydroxylation of estradiol: A possible risk marker for breast cancer
8. Effects of obesity on estradiol metabolism: Decreased formation of non-uterotropic metabolites
9. Increased estrogen-16α-hydroxylase activity in women with breast and endometrial cancer
10. Urinary estrogen metabolites and breast cancer: A case-control study
11. Urinary 2/16 α-hydroxyestrone ratio: Correlation with serum insulin-like growth factor binding protein-3 and a potential biomarker of breast cancer risk
12. Do urinary oestrogen metabolites predict breast cancer? Guernsey III cohort follow-up
13. Urinary 2-hydroxyestrone/16α-hydroxyestrone ratio and risk of breast cancer in postmenopausal women
14. Kinetics of catecholestrogen-estrogen receptor dissociation: A possible factor underlying differences in catecholestrogen biological activity
15. Binding of 2-hydroxyestradiol and 4-hydroxyestradiol to estrogen receptors from human breast cancers
16. Catecholestrogens are MCF-7 cell estrogen agonists
17. DNA single strand breaks in kidneys of Syrian hamsters treated with steroidal estrogens. Hormone-induced free radical damage preceding renal malignancy
18. 8-Hydroxylation of guanine bases in kidney and liver DNA of hamsters treated with estradiol: Role of free radicals in estrogen-induced carcinogenesis
19. 4-Hydroxylation of estrogens as marker of human mammary tumors
20. Estrogen metabolism and excretion in oriental and Caucasian women
21. Changes in levels of urinary estrogen metabolites after oral indole-3-carbinol treatment in humans
22. Effects of soy isoflavones on estrogen and phytoestrogen metabolism in premenopausal women
23. Breast cancer and diet among the Japanese in Hawaii
24. A large scale cohort study on cancer risks by diet: With special reference to the risk reducing effects of green-yellow vegetable consumption
25. Dietary effects on breast cancer risk in Singapore
26. Case-control study of phyto-oestrogens and breast cancer
27. Urinary excretion of isoflavonoids and the risk of breast cancer
28. Modest hormonal effects of soy isoflavones in postmenopausal women
29. Isoflavones in soy-based infant formulas
30. Body fat assessed from total body density and its estimation from skinfold thickness: Measurement on 481 men and women aged 16 to 72 years
31. The multicomponent analysis of estrogens in urine by ion exchange chromatography and GC-MS-I. Quantitation of estrogens after initial hydrolysis of conjugates
32. Deuterium labelled ethoximes as stable isotope internal standards in the GC-MS-SIM determination of oxo-estrogens in human urine extracts: Preliminary results
33. Isotope dilution gas chromatographic-mass spectrometric method for the determination of lignans and isoflavonoids in human urine, including identification of genistein
34. The variable metabolic response to dietary isoflavones in humans
35. Bioavailability of soybean isoflavones depends upon gut microflora in women
36. Urinary isoflavonoid excretion in humans is dose dependent at low to moderate levels of soy-protein consumption
37. Dietary phytoestrogens
38. Factors affecting the gut microflora
39. Metabolites of dietary (soya) isoflavones in human urine
40. Mammalian lignans and phytoestrogens. Recent studies on their formation, metabolism and biological role in health and disease
41. 2-Hydroxyestrone: The 'good' estrogen
42. The influence of dietary protein and carbohydrate on the principal oxidative biotransformations of estradiol in normal subjects
43. Diet and sex hormone metabolism
44. Daidzein sulfoconjugates are potent inhibitors of sterol sulfatase (EC 3.1.6.2)
45. Influence of tamoxifen on sex hormones, gonadotrophins and sex hormone binding globulin in postmenopausal breast cancer patients
46. The structure-activity relationships of flavonoids as inhibitors of cytochrome P-450 enzymes in rat liver microsomes and the mutagenicity of 2-amino-3-methyl-imidazo[4,5-f]quinoline
47. Catecholestrogens in the induction of tumors in the kidney of the Syrian hamster
48. Interaction of theophylline and ipriflavone at the cytochrome P450 level
49. Role of human hepatic cytochrome P450 1A2 and 3A4 in the metabolic activation of estrone
50. Inhibition of human aromatase by mammalian lignans and isoflavonoid phytoestrogens
51. Lignans and flavonoids inhibit aromatase enzyme in human preadipocytes
52. Dietary estrogenic isoflavones are potent inhibitors of β-hydroxysteroid dehydrogenase of P. testosteronii
53. In situ estrogen production via the estrone sulfatase pathway in breast tumors: Relative importance versus the aromatase pathway
54. Estrogen productivity of endometrium and endometrial cancer tissue: Influence of aromatase on proliferation of endometrial cancer cells